• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, August 24, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

IOF CNS Medal awarded to professor Bagher Larijani

Bioengineer by Bioengineer
April 20, 2018
in Health
Reading Time: 4 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The CNS Medal honours an individual who has made important and outstanding contributions to the International Osteoporosis Foundation (IOF) Committee of National Societies (CNS) through active participation in IOF activities and by expanding IOF's message and outreach at the national level.

The 2018 CNS Medal has been awarded today to Professor Bagher Larijani, at a ceremony held at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases in Kraków, Poland. Professor Larijani is founding Director-General and Chief Scientific Officer of the Endocrinology and Metabolism Research Institute (EMRI), a long-time, active CNS member society and the key Iranian organization in the field which carries out basic, clinical and translational research, healthcare professional education, and public awareness activities across the country.

In presenting the Award, CNS Chairman Professor Jean-Yves Reginster commended Professor Larijani and EMRI, an IOF member society. He stated: "It is a great honour to extend this prestigious Award to Professor Larijani, who is a distinguished and internationally recognized researcher as well as a dedicated advocate for osteoporosis patients in Iran. Thanks to his leadership, EMRI has carried out extensive educational outreach and national research, increased public and health professional knowledge of osteoporosis, and taken important steps forward in quantifying the burden of the disease in the country. We are also continually impressed with EMRI's exemplary campaigns on World Osteoporosis Day, which reinforce the outreach of IOF's key annual global awareness initiative."

Professor Bagher Larijani trained as an endocrinologist at Tehran University of Medical Sciences and obtained a fellowship distinction at the American College of Endocrinology. He is the founding Director-General and Chief Scientific Officer of the Endocrinology and Metabolism Research Institute (EMRI) and simultaneously holds several high-ranking governmental positions. He has served as the Chancellor of Tehran University of Medical Sciences, the oldest and most prestigious medical school in Iran, and has held the position of the Chairman of the Policy-making Council at the Ministry of Health and Medical Education. Besides his national-scale leadership roles, Professor Larijani, is currently also a practicing endocrinologist, has been involved in many research projects in different capacities, and has authored numerous journal articles and books in the fields of endocrinology, osteoporosis, medical ethics, and other related areas. His work has attained more than 16000 citations and the H-index of 62 recorded by Google Scholar in 2018.

Internationally, he has contributed to several global-scale research and policy-making conventions and assemblies such as Lancet Commission on Obesity and has been involved in different projects of the International Osteoporosis Foundation, World Health Organization and other global health-related organizations in different capacities. It is noteworthy that during the past two decades, his main interest at the Endocrinology and Metabolism Research Institute has been promoting translational medicine in Iran and bridging the gap between basic and clinical research in diabetes, osteoporosis, and other non-communicable diseases. Recently, in the capacity of Deputy Chair of the National Supreme Committee for Prevention and Control of Non-Communicable Diseases, Professor Larijani has made significant contributions to the design and development of national-scale multi-sectoral policies aimed at controlling the rampant nation-wide increase in the burden of non-communicable diseases, predicted to affect the nation dramatically in the future.

###

About the Committee of National Societies (CNS)

The CNS, comprising 240 patient and medical societies, is IOF's core membership committee. As a group it forms the world's largest single network of national patient and medical organizations dedicated to osteoporosis and musculoskeletal disorders. CNS societies are led by dedicated individuals who are deeply committed to raising public awareness and improving patient care at the national level. Their grassroots efforts in implementing IOF information campaigns locally have helped spread key prevention messages around the world. Contact an IOF member society

World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases (WCO-IOF-ESCEO Kraków 2018)

Held jointly by IOF and ESCEO, the Congress takes place in Kraków, Poland, from April 19-22, 2018. WCO-IOF-ESCEO is the world's largest annual forum for the presentation of clinical research and new advances in the prevention and management of musculoskeletal disorders, including sarcopenia and frailty. For complete information visit http://www.wco-iof-esceo.org #OsteoCongress

About IOF

The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization dedicated to the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases. IOF members, including committees of scientific researchers as well as 240 patient, medical and research societies in 99 locations, work together to make fracture prevention and healthy mobility a worldwide heath care priority. http://www.iofbonehealth.org http://www.facebook.com/ @iofbonehealth

About ESCEO

The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) is a non-profit organization, dedicated to a close interaction between clinical scientists dealing with rheumatic disorders, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of osteoporosis and osteoarthritis within the comprehensive perspective of health resources utilization. The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception. http://www.esceo.org

Media Contact

L. Misteli
[email protected]
@iofbonehealth

http://www.iofbonehealth.org

Share13Tweet8Share2ShareShareShare2

Related Posts

Integrating Life Stories for Patient-Centered Care

Integrating Life Stories for Patient-Centered Care

August 24, 2025
blank

Tailored Protein Advice Boosts Nutrition in Older Adults

August 24, 2025

Comparing Cumulative Deficit Models for Measuring Frailty

August 24, 2025

China’s Nurses Tackle Inadvertent Perioperative Hypothermia

August 24, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    141 shares
    Share 56 Tweet 35
  • Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    130 shares
    Share 52 Tweet 33
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    115 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Integrating Life Stories for Patient-Centered Care

Tailored Protein Advice Boosts Nutrition in Older Adults

Squirrel Landings Impact Ants and Arboreal Arthropods

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.